Correlation Between Rasna Therapeutics and Kane Biotech

Can any of the company-specific risk be diversified away by investing in both Rasna Therapeutics and Kane Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rasna Therapeutics and Kane Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rasna Therapeutics and Kane Biotech, you can compare the effects of market volatilities on Rasna Therapeutics and Kane Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rasna Therapeutics with a short position of Kane Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rasna Therapeutics and Kane Biotech.

Diversification Opportunities for Rasna Therapeutics and Kane Biotech

0.0

Correlation Coefficient

Rasna Therapeutics  Kane Biotech

Pay attention - limited upside

The 3 months correlation between Rasna and Kane is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Rasna Therapeutics and Kane Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kane Biotech and Rasna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rasna Therapeutics are associated (or correlated) with Kane Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kane Biotech has no effect on the direction of Rasna Therapeutics i.e., Rasna Therapeutics and Kane Biotech go up and down completely randomly.

Pair Corralation between Rasna Therapeutics and Kane Biotech

Given the investment horizon of 90 days Rasna Therapeutics is expected to generate 9.29 times more return on investment than Kane Biotech. However, Rasna Therapeutics is 9.29 times more volatile than Kane Biotech. It trades about 0.06 of its potential returns per unit of risk. Kane Biotech is currently generating about 0.03 per unit of risk. If you would invest  2.50  in Rasna Therapeutics on September 24, 2024 and sell it today you would lose (2.10) from holding Rasna Therapeutics or give up 84.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

Rasna Therapeutics  vs.  Kane Biotech

Rasna Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Rasna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Rasna Therapeutics is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Kane Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kane Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's forward indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Rasna Therapeutics and Kane Biotech

The main advantage of trading using opposite Rasna Therapeutics and Kane Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rasna Therapeutics position performs unexpectedly, Kane Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kane Biotech will offset losses from the drop in Kane Biotech's long position.

The idea behind Rasna Therapeutics and Kane Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.